PROTAGONIST THERAPEUTICS INC
PTGXNASDAQ๐ #888 by market capEarnings Nov 4 ยท PostUS Equity
$142.14โฒ $1.02 (+0.72%)
๐
Pre-market$141.44โผ 0.49%Regular close ยท extended-hours price shownTrack PTGX
Get earnings, price moves & breaking news on Telegram
24hโฒ 0.7%
7dโฒ 1.8%
14dโฒ 4.2%
30dโฒ 0.7%
ytdโฒ 62.8%
1yโฒ 85.2%
๐ฆMarket Cap
$9.20B
Small Cap
๐Revenue Growth (YoY)
-89.4%
Declining
๐Gross Margin
99.9%
High
๐ตFCF Margin
46.9%
Strong
โ๏ธP/S Ratio
32.4x
Expensive
Otter Score
56
Fair
Earnings
Q3 ยท 2026Reported 2026-08-05Earnings Per Share
Actual
2.29
Expected
2.23
beat
+2.70%
YoY +516.40%
Revenue
Actual
$213.47M
Expected
$198.66M
beat
+7.50%
YoY +3749.20%
Consensus estimates
Recent quarters
Q3 2026
2.29
beat
Q2 2026
0.05
beat
Q1 2026
-0.69
miss
Q4 2025
-0.62
miss